Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-15

Clinical Trial Update: Synovial Tissue and Fat Pad Stromal Vascular Fraction Bioengineering in Patients With Knee Articular Cartilage Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating synovial tissue and fat pad stromal vascular fraction bioengineering for knee articular cartilage injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • stromal vascular fraction bioengineered product from synovial tissue and fat pad

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Cell- and Tissue-Based Therapy, Cartilage Injury | Phase 1, Phase 2 | Status: UNKNOWN